The Latest Cardiac and Vascular News
Algorithm reduces the volume of false positives from Medtronic implantable loop recorders by nearly 80% to boost medical staff productivity by focusing on meaningful cardiac arrhythmia events CAMBRIDGE, Mass., Dec. 16, 2021 /PRNewswire/ — Implicity, a leader in remote patient monitoring and cardiac data management solutions, today announced FDA clearance for a novel […]
SHENZHEN, China, Dec. 16, 2021 /PRNewswire/ — LifeTech Scientific Corporation (LifeTech, 01302.HK) announced that it has extended its agreements with Medtronic to further the strategic collaboration on the “HeartTone™ domestic pacemaker project” and to start the collaboration on domestically-made MRI-conditional pacemakers. Together with MRI-conditional leads, these products will address growing MRI-related therapeutic needs in China. […]
Recognized in the Category of Screening, Monitoring, and Diagnostics as One of the Most Promising Private Startups in the Healthcare Space OAKLAND, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) — Eko, a cardiopulmonary digital health company, has been named to the 2021 CB Insights Digital Health 150 list. The third annual ranking honors 150 […]
Pulsed Field Ablation (PFA): Promising new therapy to treat the world’s most common heart rhythm disorder, atrial fibrillation (AF). VANCOUVER, British Columbia–(BUSINESS WIRE)–Kardium Inc. announces the completion of successful first-in-human (FIH) procedures with the Globe Pulsed Field System. Dr. Vivek Reddy of Mount Sinai Hospital in New York, USA and Prof. Petr […]
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–AtaCor Medical, Inc. announced today that it has completed enrollment in its initial acute Extravascular Implantable Cardioverter Defibrillator (EV-ICD) study. Named the PASS-PULL EV-ICD Study, it is designed for acute evaluation of AtaCor’s EV-ICD lead in connection with commercially-available ICDs. Currently, when patients require ICD therapy, wires or […]
CINCINNATI, Dec. 09, 2021 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (“CinCor”), announced today the dosing of the first patient in its Phase 2 clinical trial evaluating CIN-107, a highly selective, oral small molecule inhibitor of aldosterone synthase, in patients with uncontrolled hypertension and elevated plasma aldosterone levels, referred to as […]
ST. LOUIS, Dec. 08, 2021 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced a publication in Frontiers in Cardiovascular Medicine titled “Atrial Fibrillation Ablation Using Robotic Magnetic Navigation Reduces the Incidence of Silent Cerebral Embolism.” This multi-center, prospective study […]
BELLEVUE, Wash.–(BUSINESS WIRE)–Sudden Cardiac Arrest (SCA) is the leading medical cause of death in young athletes during sport. The presence of congenital abnormalities and electrical abnormalities within the heart that cause SCA can be detected by performing a simple, noninvasive 12-lead ‘ECG’ test or electrocardiogram. The United States Coast Guard […]
NEW YORK, Dec. 7, 2021 /PRNewswire/ — LiveCare, a leader in geriatric monitoring technology, today announced the successful integration of AliveCor’s KardiaMobile® 6L, the world’s most clinically-validated personal electrocardiogram (EKG) device, within the LiveCare Link+ smart RPM gateway. Now, patients and their caregivers will receive real-time EKG monitoring at home or in skilled nursing […]
Anthos Therapeutics announces that 1287 patients enrolled across 95 global study sites in the AZALEA-TIMI 71 Ph2 study evaluating the safety and tolerability of abelacimab compared to rivaroxaban Abelacimab is a monoclonal antibody with dual activity against Factor XI and Factor XIa administered monthly CAMBRIDGE, Mass., Dec. 7, 2021 /PRNewswire/ — Anthos Therapeutics, […]
